Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Aug;23(3):412-4.
doi: 10.5021/ad.2011.23.3.412. Epub 2011 Aug 18.

A Case of Cutaneous Side Effect of Methotrexate Mimicking Behçet's Disease

Affiliations
Case Reports

A Case of Cutaneous Side Effect of Methotrexate Mimicking Behçet's Disease

Hyun Jae Lee et al. Ann Dermatol. 2011 Aug.

Abstract

Methotrexate (MTX) is an antimetabolite which interferes with DNA synthesis, and it is used for the treatment of moderate to severe psoriasis, atopic dermatitis and a wide variety of cutaneous diseases. Although many adverse effects of MTX, including cutaneous ulcerations, have been documented, multifocal mucosal ulceration mimicking Behçet's disease has not been reported. In our case, a 63-year-old female presented with oral, vaginal ulcer and multiple purpuric patches on both legs. Considering patient's clinical course and histopathologic findings, we presumed that these reactions may be the side effect of MTX administered for treatment of necrotizing scleritis. Herein we report the cutaneous side effect of MTX that manifested clinically like Behçet's disease.

Keywords: Adverse reaction; Behçet's disease; Methotrexate.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multiple erythematous erosions in the oral cavity.
Fig. 2
Fig. 2
Erythematous ulcers on the lower extremities.
Fig. 3
Fig. 3
(A) Multiple erosive erythematous to purpuric crusted patches and papules on both legs. (B) Flattening of rete ridges, dyskeratotic keratinocytes in the epidermis, and vacuolar degeneration and hyperpigmentation of basal cell layer. In the dermis, mild vascular proliferation and perivascular infiltration of lymphocytes were demonstrated. No evidence of vasculitis was seen (A: H&E ×100).

Similar articles

Cited by

References

    1. Kazlow DW, Federgrun D, Kurtin S, Lebwohl MG. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol. 2003;49:S197–S198. - PubMed
    1. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005;64(Suppl 2):ii83–ii86. - PMC - PubMed
    1. Roenigk HH, Jr, Auerbach R, Maibach HI, Weinstein GD. Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol. 1988;19:145–156. - PubMed
    1. Varela CR, McNamara J, Antaya RJ. Acral erythema with oral methotrexate in a child. Pediatr Dermatol. 2007;24:541–546. - PubMed
    1. Pearce HP, Wilson BB. Erosion of psoriatic plaques: an early sign of methotrexate toxicity. J Am Acad Dermatol. 1996;35:835–838. - PubMed

Publication types